You are using a browser that is no longer supported for this website.
Please use the latest version of Chrome, Firefox, Edge or Safari.


Berlin Heart Enrolls First Patients in Clinical Study to Investigate Innovative Mobilization Option for Children Waiting for a Heart Transplantation

Clinical Research helps Berlin Heart to pursue a very clear vision: “With our life-saving therapies, we want to improve the quality of life of children with heart failure,” explains Dr. med. Ares K. Menon, Managing Director of Berlin Heart. “Conducting this study is another example of how Berlin Heart gives patients, parents and clinical partners a voice to target patient-centered innovations.”


More about EXCOR® Active: https://www.berlinheart.de/en/medical-professionals/excorr-active/
For more information about the “E-Motion” study, please visit:  https://clinicaltrials.gov/ct2/show/NCT04634708

EXCOR® Active is not FDA approved.